The Deloitte report establishes that a fair market value of the Aevum shares (that is the consideration offered for the merger) is between $1.24 and $1.42 per share. If the Scheme is approved by the shareholders the Court may approve the Scheme at a second hearing; s 411(4)(b). IOR Group Limited [2009] FCA 1588 (23 December 2009) In the case of the present Scheme the plaintiff has drawn my attention to a number of factors that are considered below. (f) Accordingly, the Scheme is fair and reasonable and in the best interests of IOR shareholders.